SCHEMBL8177293

SCHEMBL8177293

NS(=O)(=O)c1ccc(-c2n[nH]c(C(=O)OCc3ccccc3)c2-c2ccc(Cl)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.43
PTGS1 P23219 2/20 0.43
GCGR P47871 1/20 0.41
TTK P33981 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CA1 P00915 6/20 0.41
CA2 P00918 6/20 0.41
CA9 Q16790 5/20 0.40
CA12 O43570 4/20 0.40
CA7 P43166 3/20 0.40
CA4 P22748 2/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
DHODH Q02127 1/20 0.40
CA5A P35218 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
CDC25B P30305 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8175431 0.90 ALDH1A1 (0.43) PTGS2PTGS1GCGRALDH1A1HPGD
SCHEMBL8181133 0.85 CDC25B (0.53) PTGS2PTGS1CA1CA2CA9
SCHEMBL8179843 0.82 CA1 (0.55) PTGS2PTGS1TTKCA1CA2
SCHEMBL7773067 0.81 PTGS2 (0.47) PTGS2PTGS1TTKCA1CA2
SCHEMBL7778249 0.81 PTGS2 (0.52) PTGS2PTGS1TTKCA1CA2
SCHEMBL7779394 0.81 CA1 (0.54) PTGS2CA1CA2CA9CA12
SCHEMBL8174619 0.80 CA1 (0.46) PTGS2PTGS1TTKCA1CA2
SCHEMBL7772912 0.79 CA1 (0.52) PTGS2PTGS1TTKCA1CA2
SCHEMBL8632186 0.79 CA1 (0.51) PTGS2PTGS1TTKALDH1A1CA1
SCHEMBL7777129 0.77 PTGS2 (0.42) PTGS2PTGS1TTKCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed